Cidara Therapeutics Inc
F:20D0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cidara Therapeutics Inc
F:20D0
|
US |
|
ArcBest Corp
NASDAQ:ARCB
|
US |
|
T
|
T-Mobile US Inc
SWB:TM5
|
US |
|
J
|
Johnson & Johnson
BMV:JNJ
|
US |
|
BYD Co Ltd
OTC:BYDDF
|
CN |
|
Lufax Holding Ltd
NYSE:LU
|
CN |
|
S
|
Sinopharm Group Co Ltd
F:X2S
|
CN |
|
Biogaia AB
OTC:BIOGY
|
SE |
|
Insurance Australia Group Ltd
ASX:IAG
|
AU |
|
Chunghwa Telecom Co Ltd
F:CHWD
|
TW |
|
M
|
Mitsubishi Heavy Industries Ltd
F:MIH
|
JP |
|
Roche Holding AG
OTC:RHHVF
|
CH |
|
S
|
Securitas AB
LSE:0IAH
|
SE |
|
UDR Inc
NYSE:UDR
|
US |
|
V
|
Veranda Resort PCL
SET:VRANDA
|
TH |
|
Lancaster Colony Corp
NASDAQ:LANC
|
US |
Multiples-Based Value
The Multiples-Based Value for
Cidara Therapeutics Inc (20D0) under the Base Case is hidden
EUR.
Compared with the current market price of 183 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.